CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-03-01 | Chang David J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2024-03-01 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +353,000 | 353,000 | ||
| 2024-03-01 | Marda Anup Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2024-03-01 | Das Arun Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-03-01 | Binder Gwendolyn See Remarks | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2024-01-19 | Binder Gwendolyn See Remarks | Option exercise | +11,000 | $1.01 | $11K | 31,000 |
| 2024-01-19 | Binder Gwendolyn See Remarks | Sale | −10,300 | $19.54 | $201K | 20,700 |
| 2024-01-19 | Binder Gwendolyn See Remarks | Sale | −700 | $20.33 | $14K | 20,000 |
| 2024-01-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) | −11,000 | 100,756 | ||
| 2023-12-19 | Binder Gwendolyn See Remarks | Option exercise | +11,000 | $1.01 | $11K | 31,000 |
| 2023-12-19 | Binder Gwendolyn See Remarks | Sale | −7,868 | $21.76 | $171K | 23,132 |
| 2023-12-19 | Binder Gwendolyn See Remarks | Sale | −3,132 | $22.22 | $70K | 20,000 |
| 2023-12-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) | −11,000 | 111,756 | ||
| 2023-11-20 | Binder Gwendolyn See Remarks | Option exercise | +11,000 | $1.01 | $11K | 31,000 |
| 2023-11-20 | Binder Gwendolyn See Remarks | Sale | −3,542 | $17.39 | $62K | 27,458 |
| 2023-11-20 | Binder Gwendolyn See Remarks | Sale | −7,458 | $18.02 | $134K | 20,000 |
| 2023-11-20 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) | −11,000 | 122,756 | ||
| 2023-10-19 | Binder Gwendolyn See Remarks | Option exercise | +11,000 | $1.01 | $11K | 31,000 |
| 2023-10-19 | Binder Gwendolyn See Remarks | Sale | −10,592 | $13.32 | $141K | 20,408 |
Page 8 of 13 · 256 trades